glp 1 agonists and sglt2 inhibitors vs. GLP-1 to Treat the Heart, the Kidneys the Brain Benefits of treatment with SGLT2i

The influence of GLP-1 analogs there can quickly spread throughout the brain, Skibicka says

Curr Diabetes Rev 19:3145 Gejl M, Gjedde A, Egefjord L et al (2016) In Alzheimers disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial

Unlike GLP-1RAs, particularly dulaglutide (254), SGLT-2 inhibitors have not demonstrated cardiovascular benefits in primary prevention among individuals with multiple cardiovascular risk factors (261)

Tirzepatide produces roughly two to three times more weight loss than phentermine across every measure

[DOI] [PMC free article] [PubMed] [Google Scholar] 62.Turton M.D., D O.S., Gunn I., Beak S.A., Edwards C.M., Meeran K

They figured out how to get it past your stomach acid so it works